M. Lodola

Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism as a potential novel metabolism in chronic lymphocytic leukemia.

B. Di Camillo, A. Orlacchio, F. Ricci, 2011, Cancer biomarkers : section A of Disease markers.

ZAP-70, IgVh ,an dcytogenetic sfo rassessing prognosis in chronic lymphocytic leukemia

F. Ricci, M. Nichelatti, A. Tedeschi, 2010 .

ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia.

F. Ricci, M. Nichelatti, A. Tedeschi, 2010, Cancer biomarkers : section A of Disease markers.

Nilotinib induced bone marrow CD34+/lin–Ph+ cells early clearance in newly diagnosed CP‐chronic myeloid leukemia

B. Di Camillo, R. Cairoli, G. Rossi, 2018, American journal of hematology.

Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment.

B. Camillo, F. Lanza, R. Cairoli, 2017, Cancer biomarkers : section A of Disease markers.

Immunocomplexes in normal blood donors and in melanoma patients

M. Lodola, E. Clerici, C. Masserini, 1981 .

Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment

B. Di Camillo, R. Cairoli, G. Rossi, 2019, PloS one.

Microarray demonstrates different gene expression profiling signatures between Waldenström macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.

B. Di Camillo, F. Ricci, A. Tedeschi, 2013, Clinical lymphoma, myeloma & leukemia.